Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo.
We used gene expression profiling of human primary cells infected in vitro with dengue virus (DENV) as a tool to identify secreted mediators induced in response to the infection. Affymetrix GeneChip analysis of human primary monocytes, B cells and dendritic cells infected with DENV in vitro showed strong induction of monocyte chemotactic protein 2 (MCP-2/CCL8), interferon gamma-induced protein 10 (IP-10/CXCL10) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/TNFSF10). The expression of these genes was confirmed in dendritic cells infected with DENV in vitro at mRNA and protein levels. A prospectively enrolled cohort of DENV-infected Venezuelan patients was used to measure the levels of these proteins in serum during three different periods of the disease. Results showed significant increase of MCP-2, IP-10, and TRAIL levels in patients infected with DENV during the febrile period, when compared to healthy donors and patients with other febrile illnesses. MCP-2 and IP-10 levels were still elevated during the post-febrile period while TRAIL levels dropped close to normal after defervescense. Patients with primary infections had higher TRAIL levels than patients with secondary infections during the febrile period of the disease. Increased levels of IP-10, TRAIL and MCP-2 in acute DENV infections suggest a role for these mediators in the immune response to the infection. MCP-2 was identified in this work as a new unreported and important dengue-related protein and IP-10 was confirmed as a novel and strong pro-inflammatory marker in acute disease.
Becerra
Aniuska
A
Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, 01655, USA.
Warke
Rajas V
RV
Martin
Katherine
K
Xhaja
Kris
K
de Bosch
Norma
N
Rothman
Alan L
AL
Bosch
Irene
I
D000293:Adolescent; D000328:Adult; D001402:B-Lymphocytes / Q000821:virology; D002478:Cells, Cultured; D054412:Chemokine CCL8 / Q000096:biosynthesis / Q000097:blood; D054357:Chemokine CXCL10 / Q000096:biosynthesis / Q000097:blood; D002648:Child; D015331:Cohort Studies; D003713:Dendritic Cells / Q000821:virology; D003715:Dengue / Q000276:immunology*; D003716:Dengue Virus / Q000276:immunology* / Q000502:physiology*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000821:virology; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000096:biosynthesis / Q000097:blood; D014687:Venezuela; D055815:Young Adult
C515453:CCL8 protein, human; C114753:CXCL10 protein, human; D054412:Chemokine CCL8; D054357:Chemokine CXCL10; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human